kr250.00
0.40% yesterday
Oslo, Nov 21, 04:08 pm CET
ISIN
NO0010159684
Symbol
MEDI

Medistim Stock price

kr249.00
+9.00 3.75% 1M
+36.00 16.90% 6M
+99.50 66.56% YTD
+108.00 76.60% 1Y
+2.50 1.01% 3Y
+44.00 21.46% 5Y
+201.00 418.75% 10Y
+236.67 1,920.04% 20Y
Oslo, Closing price Fri, Nov 21 2025
+0.00 0.00%
ISIN
NO0010159684
Symbol
MEDI

Key metrics

Basic
Market capitalization
kr4.5b
Enterprise Value
kr4.4b
Net debt
positive
Cash
kr157.7m
Shares outstanding
18.3m
Valuation (TTM | estimate)
P/E
32.0 | 35.1
P/S
6.8 | 6.9
EV/Sales
6.6 | 6.7
EV/FCF
23.0
P/B
10.8
Dividends
DPS
kr6.00
Yield 1Y | 5Y
2.4% | 1.8%
Growth 1Y | 5Y
33.3% | 16.9%
Payout 1Y | 3Y
105.8% | 85.3%
Increased
1 Year
Financials (TTM | estimate)
Revenue
kr668.6m | kr655.9m
EBITDA
kr204.1m | kr191.8m
EBIT
kr179.7m | kr173.4m
Net Income
kr142.4m | kr129.7m
Free Cash Flow
kr191.0m
Growth (TTM | estimate)
Revenue
22.2% | 16.6%
EBITDA
33.8% | 23.3%
EBIT
41.0% | 32.3%
Net Income
40.1% | 24.9%
Free Cash Flow
63.6%
Margin (TTM | estimate)
Gross
81.2%
EBITDA
30.5% | 29.2%
EBIT
26.9%
Net
21.3% | 19.8%
Free Cash Flow
28.6%
Financial Health
Equity Ratio
75.9%
Return on Equity
23.8%
ROCE
40.2%
ROIC
-
Debt/Equity
0.1
More
EPS
kr7.8
FCF per Share
kr10.5
Short interest
-
Employees
154
Rev per Employee
kr3.7m
Show more

Is Medistim a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

Medistim Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Medistim forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Medistim forecast:

Buy
75%
Hold
25%

Financial data from Medistim

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
669 669
22% 22%
100%
- Direct Costs 126 126
10% 10%
19%
543 543
25% 25%
81%
- Selling and Administrative Expenses 220 220
23% 23%
33%
- Research and Development Expense - -
-
-
204 204
34% 34%
31%
- Depreciation and Amortization 24 24
3% 3%
4%
EBIT (Operating Income) EBIT 180 180
41% 41%
27%
Net Profit 142 142
40% 40%
21%

In millions NOK.

Don't miss a Thing! We will send you all news about Medistim directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. It operates through the following segments: Lease of Equipment, Capital Sales/Consumables, and Third Party Products. The Lease of Equipment segment delivers system and probes at the customer site free of charge. The Capital Sales/Consumables segment consists of probe sales, lease, and PPP cards. The Third Party Products segment offers products related with surgery. Its products include MiraQ Cardiac, MiraQ Vascular, MiraQ Ultimate, Imaging Probe, and Flow Probe. The company was founded by Kari Mette Tjolsen Pah on June 10, 1984 and is headquartered in Oslo, Norway.

Head office Norway
CEO Kari Krogstad
Employees 154
Founded 1984
Website medistim.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today